Clinical Trials
6 trialsNCT06136559 2026-05-28
BELLWAVE-011
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT04728893 2026-05-26
MK-1026-003
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT05947851 2026-05-18
BELLWAVE-010
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT05673460 2026-05-13
MK-1026-002
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT05347225 2026-04-30
MK-1026-005
Merck Sharp & Dohme LLC
Phase 1 Active not recruiting
NCT05624554 2026-03-16
A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting